Chester County News and Community Website
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) has successfully completed enrollment in the Phase 3 SELVA clinical trial of QTORIN™ 3.9% rapamycin anhydrous gel, a potential breakthrough treatment for …
Palvella Therapeutics Announces Completion of Phase 3 SELVA Trial for QTORIN Rapamycin Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has launched a Phase 1a/1b clinical program to evaluate the safety and efficacy of ATI-052, an investigational bispecific anti-TSLP/IL-4R antibody that could …
Aclaris Therapeutics Begins Phase 1a/1b Trial for Investigational Bispecific Antibody ATI-052 Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has initiated an immediate review of clinical trials involving the international transfer of Americans’ living cells for genetic engineering and subsequent …
FDA Investigates Clinical Trials Sending U.S. DNA Overseas Read More
WASHINGTON, D.C. — The Centers for Disease Control and Prevention (CDC) has issued a food safety alert in connection with an ongoing multistate Listeria outbreak tied to FreshRealm chicken fettuccine alfredo …
CDC Warns of Deadly Listeria Outbreak Linked to Recalled Chicken Alfredo Meals Read More
WASHINGTON, D.C. — The Centers for Disease Control and Prevention (CDC) has issued a food safety alert following a multistate outbreak of Salmonella infections linked to pistachio cream. Four individuals in …
CDC Warns of Salmonella Outbreak Linked to Pistachio Cream Read More
PHOENIXVILLE, PA — PleoPharma, Inc. shared encouraging findings from its Phase 2b clinical trial of PP-01, a novel treatment for Cannabis Withdrawal Syndrome (CWS), during the 2025 annual meeting of …
PleoPharma Presents Promising Phase 2b Data on PP-01 for Cannabis Withdrawal Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has received clearance from the U.S. Food and Drug Administration (FDA) to begin a Phase 2/3 pivotal confirmatory trial of OCU410ST, an innovative …
Ocugen Receives FDA Clearance for Phase 2/3 Trial of Genetic Therapy for Stargardt Disease Read More
PLYMOUTH MEETING, PA — A new study published in the June 2025 issue of JNCCN—Journal of the National Comprehensive Cancer Network highlights the life-changing impact of a telehealth-based care program …
Telehealth Program Improves Quality of Life for Older Cancer Patients, Study Finds Read More
BERWYN, PA — Panavance Therapeutics Inc. has shared promising interim findings from its ongoing Phase 1 clinical trial investigating misetionamide (GP-2250), a novel second-line therapy for advanced pancreatic cancer. These …
Panavance Therapeutics Reports Promising Phase 1 Results for Pancreatic Cancer Therapy Read More
EXTON, PA — Lungpacer Medical, Inc. has announced pivotal results from the RESCUE-3 trial, published in the American Journal of Respiratory and Critical Care Medicine, showcasing the groundbreaking benefits of …
Lungpacer Medical Publishes Landmark Findings on AeroPace System in Critical Care Read More